Isolation and characterization of a metastatic hybrid cell line generated by ER negative and ER positive breast cancer cells in mouse bone marrow

PLoS ONE

Volumn 6, Issue 6, 2011, Pages

  de Mukhopadhyay, Keya ^a   Bandyopadhyay, Abhik ^a   Chang, Ting Tung A ^b,d   Elkahloun, Abdel G ^c   Cornell, John E ^b   Yang, Junhua ^a   Goins, Beth A ^b   Yeh, I Tien ^a   Sun, Lu Zhe ^a  

^a Mays Cancer Center at UT Health San Antonio   (United States)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^c NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^d VAN ANDEL RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDEHYDE DEHYDROGENASE; BETA1 INTEGRIN; CD24 ANTIGEN; CHEMOKINE RECEPTOR CXCR4; ESTROGEN RECEPTOR; ESTROGEN RECEPTOR ALPHA; HERMES ANTIGEN; VIMENTIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW; BONE METASTASIS; BRAIN METASTASIS; BREAST CANCER; CANCER CELL; CANCER STEM CELL; CELL DIFFERENTIATION; CELL ISOLATION; CELL LINE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION PROFILING; GROWTH INHIBITION; HYBRID CELL; METASTASIS POTENTIAL; MOUSE; NONHUMAN; TUMOR GROWTH; ANIMAL; BONE MARROW CELL; BONE TUMOR; BRAIN TUMOR; BREAST TUMOR; CELL PROLIFERATION; CELL SEPARATION; CELL TRANSFORMATION; HUMAN; METABOLISM; METASTASIS; METHODOLOGY; PATHOLOGY; TUMOR CELL LINE;

MUS; MUS MUSCULUS;

ANIMALS; BONE MARROW CELLS; BONE NEOPLASMS; BRAIN NEOPLASMS; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SEPARATION; CELL TRANSFORMATION, NEOPLASTIC; FEMALE; HUMANS; MICE; NEOPLASM METASTASIS; NEOPLASTIC STEM CELLS; RECEPTORS, ESTROGEN;

EID: 79957807329     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0020473     Document Type: Article

References (48)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, et al. (2008) Cancer statistics, 2008. CA Cancer J Clin 58: 71-96.
2. Friedl P, (2005) Cell fusion: new mechanisms of plasticity in cancer? Lancet Oncol 6: 916-918.
3. Parris GE, (2006) The cell clone ecology hypothesis and the cell fusion model of cancer progression and metastasis: history and experimental support. Med Hypotheses 66: 76-83.
4. Lu X, Kang Y, (2009) Efficient acquisition of dual metastasis organotropism to bone and lung through stable spontaneous fusion between MDA-MB-231 variants. Proc Natl Acad Sci U S A 106: 9385-9390.
5. Pawelek JM, Chakraborty AK, (2008) Fusion of tumour cells with bone marrow-derived cells: a unifying explanation for metastasis. Nat Rev Cancer 8: 377-386.
6. Kaplan RN, Riba RD, Zacharoulis S, Bramley AH, Vincent L, et al. (2005) VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche. Nature 438: 820-827.
7. Tomita Y, Marchenko N, Erster S, Nemajerova A, Dehner A, et al. (2006) WT p53, but not tumor-derived mutants, bind to Bcl2 via the DNA binding domain and induce mitochondrial permeabilization. J Biol Chem 281: 8600-8606.
8. Bandyopadhyay A, Agyin JK, Wang L, Tang Y, Lei X, et al. (2006) Inhibition of pulmonary and skeletal metastasis by a transforming growth factor-beta type I receptor kinase inhibitor. Cancer Res 66: 6714-6721.
9. He X, Tsang TC, Pipes BL, Ablin RJ, Harris DT, (2005) A stem cell fusion model of carcinogenesis. J Exp Ther Oncol 5: 101-109.
10. Lu X, Kang Y, (2009) Cell fusion as a hidden force in tumor progression. Cancer Res 69: 8536-8539.
11. Duelli D, Lazebnik Y, (2003) Cell fusion: a hidden enemy? Cancer Cell 3: 445-448.
12. Miller FR, Mohamed AN, McEachern D, (1989) Production of a more aggressive tumor cell variant by spontaneous fusion of two mouse tumor subpopulations. Cancer Res 49: 4316-4321.
13. Fidler IJ, (2003) The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited. Nat Rev Cancer 3: 453-458.
14. Guise TA, Mundy GR, (1998) Cancer and bone. Endocr Rev 19: 18-54.
15. Kirsch DG, Loeffler JS, (2005) Brain metastases in patients with breast cancer: new horizons. Clin Breast Cancer 6: 115-124.
16. Klos KJ, O'Neill BP, (2004) Brain metastases. Neurologist 10: 31-46.
17. Weil RJ, Palmieri DC, Bronder JL, Stark AM, Steeg PS, (2005) Breast cancer metastasis to the central nervous system. Am J Pathol 167: 913-920.
18. Price JE, (1996) Metastasis from human breast cancer cell lines. Breast Cancer Res Treat 39: 93-102.
19. Yoneda T, Williams PJ, Hiraga T, Niewolna M, Nishimura R, (2001) A bone-seeking clone exhibits different biological properties from the MDA-MB-231 parental human breast cancer cells and a brain-seeking clone in vivo and in vitro. J Bone Miner Res 16: 1486-1495.
20. Palmieri D, Smith QR, Lockman PR, Bronder J, Gril B, et al. (2006) Brain metastases of breast cancer. Breast Dis 26: 139-147.
21. Palmieri D, Chambers AF, Felding-Habermann B, Huang S, Steeg PS, (2007) The biology of metastasis to a sanctuary site. Clin Cancer Res 13: 1656-1662.
22. Hinton CV, Avraham S, Avraham HK, (2010) Role of the CXCR4/CXCL12 signaling axis in breast cancer metastasis to the brain. Clin Exp Metastasis 27: 97-105.
23. Al Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF, (2003) Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci U S A 100: 3983-3988.
24. Collins AT, Berry PA, Hyde C, Stower MJ, Maitland NJ, (2005) Prospective identification of tumorigenic prostate cancer stem cells. Cancer Res 65: 10946-10951.
25. Li C, Heidt DG, Dalerba P, Burant CF, Zhang L, et al. (2007) Identification of pancreatic cancer stem cells. Cancer Res 67: 1030-1037.
26. O'Brien CA, Pollett A, Gallinger S, Dick JE, (2007) A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature 445: 106-110.
27. Ricci-Vitiani L, Lombardi DG, Pilozzi E, Biffoni M, Todaro M, et al. (2007) Identification and expansion of human colon-cancer-initiating cells. Nature 445: 111-115.
28. Fillmore CM, Kuperwasser C, (2008) Human breast cancer cell lines contain stem-like cells that self-renew, give rise to phenotypically diverse progeny and survive chemotherapy. Breast Cancer Res 10: R25.
29. Wicha MS, Liu S, Dontu G, (2006) Cancer stem cells: an old idea-a paradigm shift. Cancer Res 66: 1883-1890.
30. Chiang AC, Massague J, (2008) Molecular basis of metastasis. N Engl J Med 359: 2814-2823.
31. Clarke MF, Fuller M, (2006) Stem cells and cancer: two faces of eve. Cell 124: 1111-1115.
32. Duester G, (2000) Families of retinoid dehydrogenases regulating vitamin A function: production of visual pigment and retinoic acid. Eur J Biochem 267: 4315-4324.
33. Magni M, Shammah S, Schiro R, Mellado W, Dalla-Favera R, et al. (1996) Induction of cyclophosphamide-resistance by aldehyde-dehydrogenase gene transfer. Blood 87: 1097-1103.
34. Sophos NA, Vasiliou V, (2003) Aldehyde dehydrogenase gene superfamily: the 2002 update. Chem Biol Interact 143-144: 5-22.
35. Yoshida A, Rzhetsky A, Hsu LC, Chang C, (1998) Human aldehyde dehydrogenase gene family. Eur J Biochem 251: 549-557.
36. Armstrong L, Stojkovic M, Dimmick I, Ahmad S, Stojkovic P, et al. (2004) Phenotypic characterization of murine primitive hematopoietic progenitor cells isolated on basis of aldehyde dehydrogenase activity. Stem Cells 22: 1142-1151.
37. Hess DA, Meyerrose TE, Wirthlin L, Craft TP, Herrbrich PE, et al. (2004) Functional characterization of highly purified human hematopoietic repopulating cells isolated according to aldehyde dehydrogenase activity. Blood 104: 1648-1655.
38. Hess DA, Wirthlin L, Craft TP, Herrbrich PE, Hohm SA, et al. (2006) Selection based on CD133 and high aldehyde dehydrogenase activity isolates long-term reconstituting human hematopoietic stem cells. Blood 107: 2162-2169.
39. Matsui W, Huff CA, Wang Q, Malehorn MT, Barber J, et al. (2004) Characterization of clonogenic multiple myeloma cells. Blood 103: 2332-2336.
40. Ginestier C, Hur MH, Charafe-Jauffret E, Monville F, Dutcher J, et al. (2007) ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell 1: 555-567.
41. Dontu G, Abdallah WM, Foley JM, Jackson KW, Clarke MF, et al. (2003) In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells. Genes Dev 17: 1253-1270.
42. Bandyopadhyay A, Elkahloun A, Baysa SJ, Wang L, Sun LZ, (2005) Development and gene expression profiling of a metastatic variant of the human breast cancer MDA-MB-435 cells. Cancer Biol Ther 4: 168-174.
43. Mulder KM, Brattain MG, (1989) Effects of growth stimulatory factors on mitogenicity and c-myc expression in poorly differentiated and well differentiated human colon carcinoma cells. Mol Endocrinol 3: 1215-1222.
44. Sun L, Wu G, Willson JK, Zborowska E, Yang J, et al. (1994) Expression of transforming growth factor beta type II receptor leads to reduced malignancy in human breast cancer MCF-7 cells. J Biol Chem 269: 26449-26455.
45. Wipke BT, Wang Z, Kim J, McCarthy TJ, Allen PM, (2002) Dynamic visualization of a joint-specific autoimmune response through positron emission tomography. Nat Immunol 3: 366-372.
46. Wipke BT, Wang Z, Nagengast W, Reichert DE, Allen PM, (2004) Staging the initiation of autoantibody-induced arthritis: a critical role for immune complexes. J Immunol 172: 7694-7702.
47. Bandyopadhyay A, Wang L, Agyin J, Tang Y, Lin S, et al. (2010) Doxorubicin in combination with a small TGFbeta inhibitor: a potential novel therapy for metastatic breast cancer in mouse models. PLoS One 5: e10365.
48. Gentleman R, Carey V, Huber W, Irizarry R, Dudoit S, (2005) Bioinformatics and Computational Biology Solutions using R and Bioconductor. Dordrecht Springer-Verlag New York Inc. pp. 473 p.